https://www.marketscreener.com/quote/stock/FORESEE-PHARMACEUTICALS-C-45304233/news/Foresee-Pharmaceuticals-announces-the-submission-of-a-phase-3-IND-to-US-FDA-for-FP-001-42-mg-in-pa-41028481/?utm_source=telegram&utm_medium=social&utm_campaign=share